Health Care Stocks On The Rise With Help From 5 Stocks

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 23 points (-0.2%) at 15,311 as of Wednesday, Sept. 25, 2013, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,760 issues advancing vs. 1,167 declining with 109 unchanged.

The Health Care sector currently sits up 0.9% versus the S&P 500, which is up 0.1%. Top gainers within the sector include Merck ( MRK), up 0.7%, and Eli Lilly and Company ( LLY), up 0.8%. On the negative front, top decliners within the sector include Baxter International ( BAX), down 6.3%, Stryker Corporation ( SYK), down 2.3%, Zimmer Holdings ( ZMH), down 1.6%, WellPoint ( WLP), down 1.2% and Novo Nordisk A/S ( NVO), down 0.9%.

TheStreet would like to highlight 5 stocks pushing the sector higher today:

5. MAKO Surgical Corporation ( MAKO) is one of the companies pushing the Health Care sector higher today. As of noon trading, MAKO Surgical Corporation is up $13.32 (82.4%) to $29.49 on heavy volume. Thus far, 35.7 million shares of MAKO Surgical Corporation exchanged hands as compared to its average daily volume of 851,100 shares. The stock has ranged in price between $29.46-$29.59 after having opened the day at $29.49 as compared to the previous trading day's close of $16.17.

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. MAKO Surgical Corporation has a market cap of $765.6 million and is part of the health services industry. Shares are up 26.7% year to date as of the close of trading on Tuesday. Currently there are 3 analysts that rate MAKO Surgical Corporation a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates MAKO Surgical Corporation as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full MAKO Surgical Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, HCA Holdings ( HCA) is up $0.40 (1.0%) to $41.85 on average volume. Thus far, 1.2 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $41.56-$42.13 after having opened the day at $41.78 as compared to the previous trading day's close of $41.45.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $18.8 billion and is part of the health services industry. Shares are up 39.2% year to date as of the close of trading on Tuesday. Currently there are 13 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, poor profit margins and feeble growth in its earnings per share. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Intuitive Surgical ( ISRG) is up $4.61 (1.3%) to $368.50 on average volume. Thus far, 381,573 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 661,300 shares. The stock has ranged in price between $367.86-$379.99 after having opened the day at $378.17 as compared to the previous trading day's close of $363.89.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $14.7 billion and is part of the health services industry. Shares are down 24.4% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Herbalife ( HLF) is up $2.56 (3.7%) to $71.52 on light volume. Thus far, 1.2 million shares of Herbalife exchanged hands as compared to its average daily volume of 3.6 million shares. The stock has ranged in price between $68.87-$71.86 after having opened the day at $69.17 as compared to the previous trading day's close of $68.96.

Herbalife Ltd., through its subsidiaries, produces and distributes weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products worldwide. Herbalife has a market cap of $7.1 billion and is part of the consumer non-durables industry. Shares are up 109.7% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate Herbalife a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Herbalife as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Herbalife Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is up $2.07 (3.4%) to $63.01 on heavy volume. Thus far, 4.3 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.2 million shares. The stock has ranged in price between $61.02-$63.47 after having opened the day at $61.17 as compared to the previous trading day's close of $60.94.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $50.7 billion and is part of the health services industry. Shares are up 15.3% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: How Do You Make Money in a Clueless Market?

Jim Cramer's 'Mad Money' Recap: How Do You Make Money in a Clueless Market?

MAKO Surgical Corporation (MAKO) Marked As A Barbarian At The Gate

MAKO Surgical Corporation (MAKO) Marked As A Barbarian At The Gate

'Mad Money' Lightning Round: Sirius XM Goes Higher

'Mad Money' Lightning Round: Sirius XM Goes Higher

Jim Cramer's 'Mad Money' Recap: 10 to Hold the Rest of the Year

Jim Cramer's 'Mad Money' Recap: 10 to Hold the Rest of the Year

Jim Cramer's 7 Stocks in 60 Seconds: FB CCL BA JBL ISRG KBH LEN (Update 1)

Jim Cramer's 7 Stocks in 60 Seconds: FB CCL BA JBL ISRG KBH LEN (Update 1)